Portfolio company
Binx Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops molecular point-of-care diagnostic platforms for rapid chlamydia and gonorrhea testing, serving clinics, student health centres and urgent care providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Testmate Health
This company develops rapid urine-based diagnostic kits for individuals to test for sexually transmitted infections at home without requiring laboratory processing.
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
Visby Medical
This company develops portable, single-use molecular diagnostic devices for clinicians and consumers to detect infectious diseases, including respiratory and sexual health conditions.
Rapidemic
Rapidemic develops molecular point-of-care diagnostic tests for sexually transmitted infections, providing results for patients and clinicians without requiring laboratory infrastructure or external power.
TBD HEALTH
This company provides at-home screening kits and clinical services for sexually transmitted infections to individuals seeking private sexual healthcare.
StatDx
This company develops point-of-care molecular diagnostic systems for healthcare providers to identify infectious diseases and critical care conditions.
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
